Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2002
01/31/2002CA2416544A1 Mu-conopeptides
01/31/2002CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
01/31/2002CA2416505A1 Method for isolating and characterizing nucleic acid sequences
01/31/2002CA2416496A1 Adhesion molecules
01/31/2002CA2416488A1 Codon-optimized papilloma virus sequences
01/31/2002CA2416472A1 Nucleic acids compositions conferring dwarfing phenotype
01/31/2002CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/31/2002CA2416414A1 Human kinases
01/31/2002CA2416381A1 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
01/31/2002CA2416287A1 Omega-conopeptides
01/31/2002CA2416247A1 Acyl coenzyme a thioesterases
01/31/2002CA2416159A1 Fermentation process for epothilones
01/31/2002CA2415960A1 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
01/31/2002CA2415586A1 Helicobacter pylori with modified lipopolysaccharide biosynthesis
01/31/2002CA2415077A1 Cell cycle proteins and mitosis-associated molecules
01/31/2002CA2413851A1 Modified virus having an altered tropism
01/31/2002CA2412626A1 Il-17 molecules and uses thereof
01/31/2002CA2412544A1 Polypeptide delivery ii-2
01/31/2002CA2412400A1 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof
01/31/2002CA2409415A1 Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures
01/31/2002CA2353106A1 A pcr-based multiplex assay for determining haplotype
01/30/2002EP1176423A1 Surface-attached polyfunctional polymer networks for sensor chips
01/30/2002EP1176413A2 Method of making high density arrays
01/30/2002EP1176215A2 Amplification and detection of mycoplasma pneumoniae
01/30/2002EP1176214A2 Methods for amplifying and detecting Bordetella pertussis
01/30/2002EP1176213A2 Amplification and detection of legionella pneumophila nucleic acids
01/30/2002EP1176211A1 Process for monitoring mutagens in plants
01/30/2002EP1176209A1 Production of Sphingomonas exopolysaccharides unattached to the surface of bacterial cells
01/30/2002EP1176207A2 Production of polyhydroxyalkanoate in plants
01/30/2002EP1176206A2 Barley DEAD box protein HVD1 gene induced by salt stress
01/30/2002EP1176205A2 Expression of alkaline phosphatase in yeast
01/30/2002EP1176204A1 Nuclease
01/30/2002EP1176203A1 Enzyme with improved NAD(H)-acceptance
01/30/2002EP1176202A1 Glucose dehydrogenase
01/30/2002EP1176201A2 Platelet-specific chimeric immunoglobulin
01/30/2002EP1176200A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
01/30/2002EP1176199A1 Tumor suppressor genes
01/30/2002EP1176198A1 Novel fetal genes
01/30/2002EP1176197A1 A transgenic animal model for cardiac arrhythmias
01/30/2002EP1176196A1 Functional genomic screen for post-transcriptional 5' and 3' regulatory elements
01/30/2002EP1176194A1 Method of cell cultivation
01/30/2002EP1176192A2 Helicobacter felis vaccine
01/30/2002EP1175910A2 Methods and compounds for prevention of graft rejection
01/30/2002EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids
01/30/2002EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
01/30/2002EP1175510A1 Mismatch repair detection
01/30/2002EP1175508A1 Optical probes and assays
01/30/2002EP1175506A2 Compound screening method
01/30/2002EP1175505A1 Combinatorial chemical library supports having indicia at coding positions and methods of use
01/30/2002EP1175504A1 Dna encoding the human vanilloid receptor vr1
01/30/2002EP1175503A1 49 human secreted proteins
01/30/2002EP1175501A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
01/30/2002EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
01/30/2002EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
01/30/2002EP1175496A1 RECOMBINANT i PENICILLIUM FUNICULOSUM /i FOR HOMOLOGOUS AND HETEROLOGOUS PROTEIN PRODUCTION
01/30/2002EP1175495A1 Microbial beta-glucuronidase genes, gene products and uses thereof
01/30/2002EP1175494A1 Beta-hexosaminidase, dna sequence from ciliates for coding the same and use thereof
01/30/2002EP1175493A1 Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants
01/30/2002EP1175492A1 Star homologues
01/30/2002EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics
01/30/2002EP1175490A2 Tyrosine kinase substrate (tks) proteins
01/30/2002EP1175489A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
01/30/2002EP1175446A1 Human antibodies that bind human il-12 and methods for producing
01/30/2002EP1175445A1 Specific antibodies and antibody fragments for tgfbeta1
01/30/2002EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs
01/30/2002EP1175442A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
01/30/2002EP1175440A1 48 human secreted proteins
01/30/2002EP1175439A1 49 human secreted proteins
01/30/2002EP1175438A1 62 human secreted proteins
01/30/2002EP1175436A2 Transiently immortalized cells for use in gene therapy
01/30/2002EP1175431A1 Substrate including anionic detergent for purifying nucleic acid
01/30/2002EP1175430A1 Antisense-oligos with better stability and antisense effect
01/30/2002EP1175228A1 Gene therapy using tgf-beta
01/30/2002EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma
01/30/2002EP1175223A2 Methods and compositions for modulating an immune response
01/30/2002EP1175144A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
01/30/2002EP1102782A4 Structural analogs of amine bases and nucleosides
01/30/2002EP1071429B1 Map kinase inhibitors in the treatment of disorders caused by tnf-alpha induced lipolysis
01/30/2002EP0956009B1 Treatment of neurodegenerative conditions with nimesulide
01/30/2002EP0929676A4 Genetic sequences encoding flavonoid pathway enzymes and uses therefor
01/30/2002EP0904539A4 Inhibiting protein interactions
01/30/2002EP0888373A4 Smooth muscle cell lim protein
01/30/2002EP0879247A4 Glial cell line-derived neurotrophic factor receptors
01/30/2002EP0730495B1 Method and apparatus for collecting a cell sample from a liquid specimen
01/30/2002EP0680605B1 Entrapment of nucleic acid sequencing template in sample mixtures by entangled polymer networks
01/30/2002EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
01/30/2002EP0617736B1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae
01/30/2002EP0596979B1 Recombinant plant viral nucleic acids
01/30/2002EP0536293B1 Increased starch content in plants
01/30/2002EP0528857B1 New bacillus thuringiensis strain and its gene encoding insecticidal toxin
01/30/2002EP0497922B1 Infective protein delivery system
01/30/2002CN1333873A HIV-specfic T-cell induction
01/30/2002CN1333837A Methods for producing polypeptides in aspergillus mutant cells
01/30/2002CN1333835A Phosphonate metabolizing plants
01/30/2002CN1333834A Vectors for transforming plants
01/30/2002CN1333833A New method of identifying non-host plant disease resistance genes
01/30/2002CN1333832A Compounds and methods for treatment and diagnosis of chlamydial infection
01/30/2002CN1333831A Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
01/30/2002CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer
01/30/2002CN1333829A Polypeptide